{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T01:57:04Z","timestamp":1788919024463,"version":"build-2803163510"},"reference-count":23,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,31]],"date-time":"2013-07-31T00:00:00Z","timestamp":1375228800000},"content-version":"vor","delay-in-days":395,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"crossref","award":["U01-HL088953"],"award-info":[{"award-number":["U01-HL088953"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1016\/j.jacc.2012.03.030","type":"journal-article","created":{"date-parts":[[2012,5,23]],"date-time":"2012-05-23T17:52:10Z","timestamp":1337795530000},"page":"388-396","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":174,"title":["Mortality Benefit With Prasugrel in the TRITON\u2013TIMI 38 Coronary Artery Bypass Grafting Cohort"],"prefix":"10.1016","volume":"60","author":[{"given":"Peter K.","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence T.","family":"Goodnough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerrold H.","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert S.","family":"Poston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary A.","family":"Short","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Govinda J.","family":"Weerakkody","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LeRoy A.","family":"LeNarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2012.03.030_bib1","first-page":"149","article-title":"Utilization of catheterization and revascularization procedures in patients with non-ST segment elevation acute coronary syndrome over the last decade","volume":"66","author":"Levine","year":"2005","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2012.03.030_bib2","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.jtcvs.2009.04.052","article-title":"Antiplatelet agents used for early intervention in acute coronary syndrome: myocardial salvage versus bleeding complications","volume":"138","author":"Aranki","year":"2009","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jacc.2012.03.030_bib3","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1161\/01.CIR.0000140675.85342.1B","article-title":"Clopidogrel in Unstable angina to prevent Recurrent ischemic Events Trial","volume":"110","author":"Fox","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2012.03.030_bib4","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1161\/01.CIR.103.3.363","article-title":"Superiority of clopidogrel versus aspirin in patients with prior cardiac surgery","volume":"103","author":"Bhatt","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2012.03.030_bib5","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/j.jacc.2009.03.006","article-title":"Outcomes following pre-operative clopidogrel administration in patients with acute coronary syndromes undergoing coronary artery bypass surgery: the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial","volume":"53","author":"Ebrahimi","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.03.030_bib6","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"Prasugrel versus clopidogrel in patients with acute coronary syndromes","volume":"357","author":"Wiviott","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2012.03.030_bib7","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.jacc.2010.10.029","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery results from the PLATO (Platelet Inhibition and Patient Outcomes) trial","volume":"57","author":"Held","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.03.030_bib8","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1016\/j.jacc.2010.05.060","article-title":"Antiplatelet therapy and coronary artery bypass graft surgery: a fallow land","volume":"56","author":"Montalescot","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.03.030_bib9","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.ahj.2008.06.034","article-title":"Clopidogrel use and bleeding after coronary artery bypass graft surgery","volume":"156","author":"Kim","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2012.03.030_bib10","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jtcvs.2004.02.019","article-title":"Clopidogrel and bleeding in patients undergoing elective coronary artery bypass grafting","volume":"128","author":"Chen","year":"2004","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jacc.2012.03.030_bib11","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.athoracsur.2009.02.092","article-title":"A review of topical hemostatic agents for use in cardiac surgery","volume":"88","author":"Barnard","year":"2009","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jacc.2012.03.030_bib12","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/eurheartj\/ehp401","article-title":"Relationship between baseline haemoglobin and major bleeding complications in acute coronary syndromes","volume":"31","author":"Bassand","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2012.03.030_bib14","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S1010-7940(99)00134-7","article-title":"European system for cardiac operative risk evaluation (EuroSCORE)","volume":"16","author":"Nashef","year":"1999","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.jacc.2012.03.030_bib15","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/0003-4975(94)90355-7","article-title":"First publications from the Society of Thoracic Surgeons National Database","volume":"57","author":"Anderson","year":"1994","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jacc.2012.03.030_bib16","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.ahj.2006.04.012","volume":"152","author":"Wiviott","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2012.03.030_bib17","doi-asserted-by":"crossref","first-page":"e215","DOI":"10.1016\/j.jacc.2011.02.011","volume":"57","author":"Wright","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.03.030_bib18","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1016\/j.jacc.2009.10.015","article-title":"American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"54","author":"Kushner","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.03.030_bib19","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0140-6736(01)05701-4","article-title":"Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study","volume":"358","author":"Mehta","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2012.03.030_bib20","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.amjcard.2006.03.040","article-title":"Challenges in predicting the need for coronary artery bypass grafting at presentation in patients with non-ST-segment elevation acute coronary syndromes","volume":"98","author":"Mehta","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2012.03.030_bib21","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S0003-4975(00)01343-6","article-title":"Abciximab and bleeding during coronary surgery: results from the EPILOG and EPISTENT trials","volume":"70","author":"Lincoff","year":"2000","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jacc.2012.03.030_bib22","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation","volume":"345","author":"Yusuf","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2012.03.030_bib23","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"Wallentin","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2012.03.030_bib24","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1182\/blood.V116.21.1108.1108","article-title":"Transfusion requirements and outcomes in the cohort of patients undergoing isolated CABG treated with prasugrel or clopidogrel: TRITON-TIMI 38 retrospective data analysis","volume":"116","author":"Goodnough","year":"2010","journal-title":"Blood"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109712012120?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109712012120?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T12:55:37Z","timestamp":1760014537000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109712012120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S0735109712012120"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2012.03.030","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mortality Benefit With Prasugrel in the TRITON\u2013TIMI 38 Coronary Artery Bypass Grafting Cohort","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2012.03.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}